Skip to main content

Beta-Blocker Therapy (i.e., Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate) for LVSD Prescribed at Discharge

CBE ID
2438
Project
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Proportion of heart failure patients age 18 and older with LVSD for whom beta-blocker therapy (i.e., bisoprolol, carvedilol, or sustained-release metoprolol succinate) is prescribed at discharge. For purposes of this measure, LVSD is defined as chart documentation of a left ventricular ejection fraction (LVEF) less than 40% or a narrative description of left ventricular systolic (LVS) function consistent with moderate or severe systolic dysfunction.

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Level Of Analysis
    Care Setting
    Numerator

    Patients who are prescribed bisoprolol, carvedilol, or sustained-release metoprolol succinate for LVSD at hospital discharge.

    Denominator

    Heart failure patients with current or prior documentation of left ventricular ejection fraction (LVSD) < 40%.

    Exclusions

    Excluded Populations:
    • Patients who had a left ventricular assistive device (LVAD) or heart transplant procedure during hospital stay (ICD-10-PCS procedure code for LVAD and heart transplant as defined in Appendix A, Table 2.2)
    • Patients less than 18 years of age
    • Patients who have a Length of Stay greater than 120 days
    • Patients with Comfort Measures Only documented
    • Patients enrolled in a Clinical Trial
    • Patients discharged to another hospital
    • Patients who left against medical advice
    • Patients who expired
    • Patients discharged to home for hospice care
    • Patients discharged to a healthcare facility for hospice care
    • Patients with a documented Reason for No Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate Prescribed for LVSD at Discharge

  • Most Recent Endorsement Activity
    Measure Retired and Endorsement Removed Cardiovascular Fall Cycle 2018
    Initial Endorsement
    Endorsement Status
    Last Updated
    Removal Date